CX-6526

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCX-6526
Drug Alias NameCX-6526
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated T-type calcium channel modulators
TargetsVoltage-gated T-type calcium channel
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCavion Inc
China Registration ClassN/A

Develop Information

Active CompaniesCavion Inc
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A